Lake Oswego, OR, United States of America

Laura M Heiser

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2016.


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment: The Contributions of Laura M Heiser

Introduction

Laura M Heiser is a prominent inventor based in Lake Oswego, OR (US). She has made significant contributions to the field of cancer research, particularly in understanding therapeutic responses to anti-cancer agents. Her work is vital in advancing personalized medicine for breast cancer patients.

Latest Patents

Heiser holds a patent titled "Molecular predictors of therapeutic response to specific anti-cancer agents." This patent describes the use of a collection of 50 breast cancer cell lines to match responses to 77 conventional and experimental therapeutic agents with transcriptional, proteomic, and genomic subtypes found in primary tumors. Almost all compounds produced strong differential responses across the cell lines, which were associated with transcriptional and proteomic subtypes. Additionally, these responses were linked to recurrent genome copy number abnormalities. The associations identified can now be incorporated into clinical trials that test subtype markers and clinical responses simultaneously. She has 1 patent to her name.

Career Highlights

Laura M Heiser is affiliated with the University of California, where she continues her research and innovation in cancer therapeutics. Her work has garnered attention for its potential to improve treatment outcomes for breast cancer patients.

Collaborations

Heiser has collaborated with notable colleagues, including William J Gibb and Paul T Spellman. Their combined expertise enhances the research efforts in understanding cancer treatment responses.

Conclusion

Laura M Heiser's innovative work in cancer research exemplifies the importance of personalized medicine. Her contributions are paving the way for more effective treatments for breast cancer patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…